Sally Cox

Sally Cox holds a BA in Journalism and a master’s in international business. Diagnosed with AL amyloidosis in 2019 following a cardiac emergency while snorkeling, she achieved remission on the control arm of the landmark ANDROMEDA trial. A passionate advocate for clinical trial participation, she has tripled support group membership since 2022 while leading awareness initiatives nationwide. After helping identify her sister-in-law’s AL amyloidosis, she champions the message that amyloidosis is not rare—just rarely diagnosed.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.